China Cellular Health Screening Market Size & Outlook
China cellular health screening market, 2018-2030 (US$M)
Related Markets
China cellular health screening market highlights
- The China cellular health screening market generated a revenue of USD 83.4 million in 2023 and is expected to reach USD 209.5 million by 2030.
- The China market is expected to grow at a CAGR of 14.1% from 2024 to 2030.
- In terms of segment, single test panels was the largest revenue generating test type in 2023.
- Multi-test Panels is the most lucrative test type segment registering the fastest growth during the forecast period.
Cellular health screening market data book summary
| Market revenue in 2023 | USD 83.4 million |
| Market revenue in 2030 | USD 209.5 million |
| Growth rate | 14.1% (CAGR from 2023 to 2030) |
| Largest segment | Single test panels |
| Fastest growing segment | Multi-test Panels |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Single Test Panels, Multi-test Panels |
| Key market players worldwide | Cytek Biosciences Inc, Quest Diagnostics Inc, Labcorp Holdings Inc, OPKO Health Inc, Applied DNA Sciences Inc |
Other key industry trends
- In terms of revenue, China accounted for 2.8% of the global cellular health screening market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan cellular health screening market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 209.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cellular Health Screening Market Scope
Cellular Health Screening Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
China cellular health screening market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cellular health screening market will help companies and investors design strategic landscapes.
Single test panels was the largest segment with a revenue share of 76.86% in 2023. Horizon Databook has segmented the China cellular health screening market based on single test panels, multi-test panels covering the revenue growth of each sub-segment from 2018 to 2030.
Noncommunicable diseases dominate the disease burden in China. These account for 70% of Disability-Adjusted Life Years lost and nearly 80% of reported deaths. Stroke, cancer, chronic respiratory disease, and cardiovascular diseases are the leading causes of increased patient burden and death.
The prevalence of noncommunicable diseases is increasing due to growing geriatric population and unhealthy lifestyle choices . An obesity epidemic is also expected; with more than 20% of children aged 7–17 in big cities being presently overweight or obese.
About 160 million adults are hypertensive and are mostly untreated. China has higher rates of death from chronic disease in the middle-aged population than in some high-income countries. According to the National Health Commission.
Reasons to subscribe to China cellular health screening market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of China cellular health screening market databook
-
Our clientele includes a mix of cellular health screening market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China cellular health screening market , including forecasts for subscribers. This country databook contains high-level insights into China cellular health screening market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
China cellular health screening market size, by test type, 2018-2030 (US$M)
China Cellular Health Screening Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
